Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
Colorectal Cancer, Metastatic Cancer
About this trial
This is an interventional treatment trial for Colorectal Cancer focused on measuring stage IV colon cancer, adenocarcinoma of the colon, stage IV rectal cancer, adenocarcinoma of the rectum, liver metastases
Eligibility Criteria
DISEASE CHARACTERISTICS:
Histologically confirmed colorectal adenocarcinoma
Hepatic metastasis (no histologic confirmation required) and no evidence of extrahepatic metastatic disease within the past 4 weeks by one of the following imaging studies*:
- PET/CT scan with contrast
- PET scan AND CT scan with contrast
- PET scan AND MRI with contrast
- PET/CT scan without contrast AND MRI with contrast NOTE: *If findings noted in imaging study reports are equivocal, the determination of whether or not the findings represent extrahepatic disease will be at the investigator's discretion.
No history of or concurrent evidence of extrahepatic metastases
- Patients with regional nodes that are suspicious on imaging and are associated with the primary colorectal tumor are eligible provided the nodes will be resected with the primary tumor after randomization
- No radiographic evidence of metastases to portal lymph nodes (node > 1 cm in diameter) unless the node(s) are proven by biopsy to be negative
- No anal, small bowel, or appendiceal carcinoma
- No sarcoma, lymphoma, or carcinoid colorectal malignant diseases
Within 4 weeks before randomization, the liver metastases must be determined by a hepatic surgeon to be resectable based on meeting both of the following criteria:
- A complete resection can be performed in a single operation
- There are ≥ 2 uninvolved contiguous segments of the liver
Meets one of the following criteria:
- Primary tumor and regional nodes resected with clear surgical margins and no evidence of extrahepatic disease
- Unresected primary tumor with plans to resect the primary tumor before randomization
- Unresected primary tumor with plans to resect the primary tumor and the liver metastases in a single surgical procedure performed after randomization
- No unresected primary tumor in the colon or rectum with significant symptoms related to obstruction or that will require radiotherapy
PATIENT CHARACTERISTICS:
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Life expectancy ≥ 5 years (excluding the diagnosis of metastatic CRC)
- absolute neutrophil count (ANC) ≥ 1,200/mm^3
- Platelet count ≥ 100,000/mm^3
- Hemoglobin ≥ 10 g/dL
- Total bilirubin ≤ upper limit of normal (ULN)
- aspartate aminotransferase (AST) ≤ 5.0 times ULN
- Alkaline phosphatase ≤ 5.0 times ULN
- Serum creatinine ≤ ULN OR calculated creatinine clearance ≥ 30 mL/min
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception during and for ≥ 180 days after completion of study treatment
- Considered a potential candidate for a major hepatic surgical procedure
- No grade 3 or 4 anorexia, grade 3 nausea, or vomiting ≥ grade 2 (per CTCAE v4.0) related to metastatic disease
- No paresthesias, peripheral sensory neuropathy, or peripheral motor neuropathy ≥ grade 2 per Common Toxicity Criteria for Adverse Effects (CTCAE) v4.0 (patients with grade 2 neuropathy who will receive FOLFIRI are eligible)
- No uncontrolled high BP defined as systolic BP ≥ 160 mm Hg OR diastolic BP ≥ 100 mm Hg, with or without antihypertensive medication (patients with initial BP elevations are eligible provided initiation or adjustment of BP medication lowers pressure to meet this criteria)
- Documented history of congestive heart failure requiring chronic medical therapy
- No active inflammatory bowel disease
- No active infection or chronic infection requiring chronic suppressive antibiotics
- No known bleeding diathesis or coagulopathy
- No symptomatic interstitial pneumonitis OR definitive evidence of interstitial pneumonitis described on CT scan, MRI, or chest x-ray in asymptomatic patients
No other malignancies unless the patient is considered to be disease-free and has completed therapy for the malignancy ≥ 1 year ago
- Patients with carcinoma in situ of the cervix, CRC in situ, melanoma in situ, or basal cell or squamous cell carcinoma of the skin diagnosed and treated at any time before study treatment are eligible
- No known Gilbert syndrome
- Not known to be homozygous for the UGT1A1 allele (for patients who will receive FOLFIRI chemotherapy)
- No prior serious hypersensitivity reaction to any of the agents administered as part of study treatment (determination of "serious" is at the investigator's discretion)
- No other serious concurrent medical condition that, in the opinion of the investigator, would compromise the safety of the patient or compromise the patient's ability to participate in the study, or cause a delay in the initiation of therapy (surgery or chemotherapy) longer than 4 weeks following randomization
- No psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements
- No pre-existing chronic hepatic disease (e.g., chronic active hepatitis, cirrhosis) that, in the opinion of the investigator and hepatic surgeon, would limit the patient's ability to undergo hepatic metastasectomy
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
No previous hepatic-directed therapy, including hepatic resection and/or ablation, hepatic arterial infusion therapy, or hepatic radiotherapy
- Patients who have only had an incision or excisional biopsy are eligible
- No previous chemotherapy or any other systemic therapy for metastatic colorectal cancer (CRC)
- No prior or concurrent portal vein embolization or other hepatic preconditioning techniques
- At least 30 days since prior investigational products
- No intent to use ablation to treat any hepatic lesion
- No concurrent therapeutic doses of coumadin or equivalent
Sites / Locations
- Kaiser Permanente - Deer Valley
- City of Hope Comprehensive Cancer Center
- Kaiser Permanente - Fremont
- Kaiser Permanente Medical Center - Hayward
- Kaiser Permanente Medical Center - Oakland
- St. Joseph Hospital Regional Cancer Center - Orange
- Kaiser Permanente Medical Center - Redwood City
- Kaiser Permanente Medical Center - Richmond
- Kaiser Permanente Medical Center - Roseville
- South Sacramento Kaiser-Permanente Medical Center
- Kaiser Permanente Medical Center - Sacramento
- Kaiser Permanente Medical Office -Vandever Medical Office
- Kaiser Permanente Medical Center - San Francisco Geary Campus
- Kaiser Permanente Medical Center - Santa Teresa
- Kaiser Foundation Hospital - San Rafael
- Kaiser Permanente Medical Center - Santa Clara Kiely Campus
- Kaiser Permanente Medical Center - Santa Rosa
- Kaiser Permanente Medical Center - South San Francisco
- Kaiser Permanente Medical Facility - Stockton
- Kaiser Permanente Medical Center - Vacaville
- Kaiser Permanente Medical Center - Vallejo
- Kaiser Permanente Medical Center - Walnut Creek
- University of Colorado Cancer Center at UC Health Sciences Center
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
- Manchester Memorial Hospital
- Tunnell Cancer Center at Beebe Medical Center
- CCOP - Christiana Care Health Services
- Washington Cancer Institute at Washington Hospital Center
- Baptist Cancer Institute - Jacksonville
- Lakeland Regional Cancer Center at Lakeland Regional Medical Center
- Florida Hospital Cancer Institute at Florida Hospital Orlando
- Veterans Affairs Medical Center - Atlanta (Decatur)
- Kaiser Permanente - Moanalua Medical Center and Clinic
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
- St. Joseph Medical Center
- Graham Hospital
- Memorial Hospital
- Decatur Memorial Hospital Cancer Care Institute
- Eureka Community Hospital
- Galesburg Clinic, PC
- Mason District Hospital
- Hinsdale Hematology Oncology Associates
- McDonough District Hospital
- BroMenn Regional Medical Center
- Community Cancer Center
- Advocate Christ Medical Center
- Community Hospital of Ottawa
- Cancer Treatment Center at Pekin Hospital
- Proctor Hospital
- CCOP - Illinois Oncology Research Association
- Oncology Hematology Associates of Central Illinois, PC - Peoria
- Methodist Medical Center of Illinois
- OSF St. Francis Medical Center
- Illinois Valley Community Hospital
- Perry Memorial Hospital
- Regional Cancer Center at Memorial Medical Center
- St. Francis Hospital and Health Centers - Beech Grove Campus
- Elkhart Clinic, LLC
- Howard Community Hospital
- Reid Hospital & Health Care Services
- CCOP - Northern Indiana CR Consortium
- Michiana Hematology-Oncology, PC - South Bend
- McFarland Clinic, PC
- Medical Oncology and Hematology Associates - West Des Moines
- Mercy Cancer Center - West Lakes
- CCOP - Iowa Oncology Research Association
- John Stoddard Cancer Center at Iowa Methodist Medical Center
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
- Medical Oncology and Hematology Associates at Mercy Cancer Center
- Mercy Cancer Center at Mercy Medical Center - Des Moines
- John Stoddard Cancer Center at Iowa Lutheran Hospital
- Holden Comprehensive Cancer Center at University of Iowa
- McCreery Cancer Center at Ottumwa Regional
- Siouxland Hematology-Oncology Associates, LLP
- Mercy Medical Center - Sioux City
- St. Luke's Regional Medical Center
- Cancer Center of Kansas, PA - Chanute
- Cancer Center of Kansas, PA - Dodge City
- Cancer Center of Kansas, PA - El Dorado
- Cancer Center of Kansas - Fort Scott
- Cancer Center of Kansas-Independence
- Cancer Center of Kansas, PA - Kingman
- Lawrence Memorial Hospital
- Cancer Center of Kansas, PA - Liberal
- Cancer Center of Kansas, PA - Newton
- Menorah Medical Center
- Saint Luke's Hospital - South
- Cancer Center of Kansas, PA - Parsons
- CCOP - Kansas City
- Cancer Center of Kansas, PA - Pratt
- Cancer Center of Kansas, PA - Salina
- Cancer Center of Kansas, PA - Wellington
- Associates in Womens Health, PA - North Review
- Cancer Center of Kansas, PA - Medical Arts Tower
- Cancer Center of Kansas, PA - Wichita
- CCOP - Wichita
- Via Christi Cancer Center at Via Christi Regional Medical Center
- Cancer Center of Kansas, PA - Winfield
- Central Baptist Hospital
- Lucille P. Markey Cancer Center at University of Kentucky
- Ochsner Health Center - Bluebonnet
- Ochsner Health Center - Covington
- CCOP - Ochsner
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
- Union Hospital of Cecil County
- Peninsula Regional Medical Center
- Berkshire Hematology Oncology, PC
- Hickman Cancer Center at Bixby Medical Center
- Saint Joseph Mercy Cancer Center
- CCOP - Michigan Cancer Research Consortium
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
- Genesys Hurley Cancer Institute
- Hurley Medical Center
- Van Elslander Cancer Center at St. John Hospital and Medical Center
- Foote Memorial Hospital
- Borgess Medical Center
- West Michigan Cancer Center
- Bronson Methodist Hospital
- Breslin Cancer Center at Ingham Regional Medical Center
- Sparrow Regional Cancer Center
- St. Mary Mercy Hospital
- Mercy Memorial Hospital - Monroe
- St. Joseph Mercy Oakland
- Mercy Regional Cancer Center at Mercy Hospital
- Seton Cancer Institute at Saint Mary's - Saginaw
- Lakeside Cancer Specialists, PLLC
- Providence Cancer Institute at Providence Hospital - Southfield Campus
- St. John Macomb Hospital
- St. Joseph's Medical Center
- Fairview Ridges Hospital
- Mercy and Unity Cancer Center at Mercy Hospital
- CCOP - Duluth
- St. Luke's Hospital Cancer Care Center
- Fairview Southdale Hospital
- Fergus Falls Medical Group, PA
- Mercy and Unity Cancer Center at Unity Hospital
- Hutchinson Area Health Care
- HealthEast Cancer Care at St. John's Hospital
- Minnesota Oncology Hematology, PA - Maplewood
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
- Hennepin County Medical Center - Minneapolis
- Humphrey Cancer Center at North Memorial Outpatient Center
- CCOP - Metro-Minnesota
- Park Nicollet Cancer Center
- United Hospital
- St. Francis Cancer Center at St. Francis Medical Center
- Regions Hospital Cancer Care Center
- Lakeview Hospital
- Ridgeview Medical Center
- Willmar Cancer Center at Rice Memorial Hospital
- Minnesota Oncology Hematology, PA - Woodbury
- Goldschmidt Cancer Center
- Saint Luke's Cancer Institute at Saint Luke's Hospital
- St. Joseph Medical Center
- North Kansas City Hospital
- Parvin Radiation Oncology
- Heartland Hematology Oncology Associates, Incorporated
- Research Medical Center
- Saint Luke's East - Lee's Summit
- Liberty Hospital
- Heartland Regional Medical Center
- Saint Louis University Cancer Center
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
- Missouri Baptist Cancer Center
- Comprehensive Cancer Care, PC
- CCOP - Cancer Research for the Ozarks
- Hulston Cancer Center at Cox Medical Center South
- CCOP - Montana Cancer Consortium
- St. Vincent Healthcare Cancer Care Services
- Hematology-Oncology Centers of the Northern Rockies - Billings
- Billings Clinic - Downtown
- Bozeman Deaconess Cancer Center
- St. James Healthcare Cancer Care
- Great Falls Clinic - Main Facility
- Sletten Cancer Institute at Benefis Healthcare
- St. Peter's Hospital
- Glacier Oncology, PLLC
- Kalispell Medical Oncology at KRMC
- Kalispell Regional Medical Center
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
- Cancer Resource Center - Lincoln
- CCOP - Missouri Valley Cancer Consortium
- Immanuel Medical Center
- Alegant Health Cancer Center at Bergan Mercy Medical Center
- Creighton University Medical Center
- Newark Beth Israel Medical Center
- Cancer Institute of New Jersey at Cooper - Voorhees
- University of New Mexico Cancer Center
- Roswell Park Cancer Institute
- Charles R. Wood Cancer Center at Glens Falls Hospital
- NYU Cancer Institute at New York University Medical Center
- Nalitt Cancer Institute at Staten Island University Hospital
- Presbyterian Cancer Center at Presbyterian Hospital
- Leo W. Jenkins Cancer Center at ECU Medical School
- Kinston Medical Specialists
- Iredell Memorial Hospital
- Forsyth Regional Cancer Center at Forsyth Medical Center
- Wake Forest University Comprehensive Cancer Center
- CCOP - MeritCare Hospital
- Mary Rutan Hospital
- Adena Regional Medical Center
- Case Comprehensive Cancer Center
- Riverside Methodist Hospital Cancer Care
- CCOP - Columbus
- Grant Medical Center Cancer Care
- Mount Carmel Health - West Hospital
- Doctors Hospital at Ohio Health
- Grandview Hospital
- Good Samaritan Hospital
- David L. Rike Cancer Center at Miami Valley Hospital
- CCOP - Dayton
- Grady Memorial Hospital
- Community Cancer Center
- Hematology Oncology Center
- Blanchard Valley Medical Associates
- Middletown Regional Hospital
- Wayne Hospital
- Charles F. Kettering Memorial Hospital
- Fairfield Medical Center
- Lima Memorial Hospital
- Strecker Cancer Center at Marietta Memorial Hospital
- Knox Community Hospital
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
- Fisher-Titus Medical Center
- St. Charles Mercy Hospital
- North Coast Cancer Care, Incorporated
- Community Hospital of Springfield and Clark County
- Flower Hospital Cancer Center
- Mercy Hospital of Tiffin
- Toledo Hospital
- St. Vincent Mercy Medical Center
- Medical University of Ohio Cancer Center
- CCOP - Toledo Community Hospital
- St. Anne Mercy Hospital
- Toledo Clinic, Incorporated - Main Clinic
- UVMC Cancer Care Center at Upper Valley Medical Center
- Fulton County Health Center
- Mount Carmel St. Ann's Cancer Center
- Ruth G. McMillan Cancer Center at Greene Memorial Hospital
- Genesis - Good Samaritan Hospital
- Oklahoma University Cancer Institute
- Natalie Warren Bryant Cancer Center at St. Francis Hospital
- Butler Memorial Hospital
- Riddle Memorial Hospital Cancer Center
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
- Allegheny Cancer Center at Allegheny General Hospital
- UPMC Cancer Centers
- McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center
- Associates in Hematology-Oncology, PC at Crozer Regional Cancer Center
- Bon Secours St. Francis Health System
- CCOP - Greenville
- Self Regional Cancer Center at Self Regional Medical Center
- Medical X-Ray Center, PC
- Sanford Cancer Center at Sanford USD Medical Center
- Thompson Cancer Survival Center
- Parkland Memorial Hospital
- Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
- Joe Arrington Cancer Research and Treatment Center
- Sandra L. Maxwell Cancer Center
- Logan Regional Hospital
- Val and Ann Browning Cancer Center at McKay-Dee Hospital Center
- Utah Valley Regional Medical Center - Provo
- Dixie Regional Medical Center - East Campus
- LDS Hospital
- Danville Regional Medical Center
- Fredericksburg Oncology, Incorporated
- Overlake Cancer Center at Overlake Hospital Medical Center
- Fred Hutchinson Cancer Research Center
- Group Health Central Hospital
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
- Community Comprehensive Cancer Center at Camden-Clark Memorial Hospital
- Marshfield Clinic - Chippewa Center
- Marshfield Clinic Cancer Care at Regional Cancer Center
- Marshfield Clinic - Marshfield Center
- Medical College of Wisconsin Cancer Center
- Marshfield Clinic - Lakeland Center
- Ministry Medical Group at Saint Mary's Hospital
- Marshfield Clinic - Indianhead Center
- Marshfield Clinic at Saint Michael's Hospital
- Marshfield Clinic - Weston Center
- Marshfield Clinic - Wisconsin Rapids Center
- Welch Cancer Center at Sheridan Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Arm 1: Postoperative chemotherapy
Arm 2: Perioperative chemotherapy
Patients undergo hepatic resection. Beginning 31-56 days after surgery, patients receive mFOLFOX6 or FOLFIRI chemotherapy IV on day 1 over 3 hours. Patients receive an additional dose of fluorouracil over 46 hours using a portable pump. Treatment repeats every 2 weeks for 12 cycles.
Patients receive mFOLFOX6 or FOLFIRI chemotherapy IV over 3 hours on day 1. Patients receive an additional dose of fluorouracil over 46 hours using a portable pump. Treatment repeats for every 2 weeks for 6 cycles. Patients then undergo hepatic resection. Beginning 31-56 days after surgery, patients receive an additional 6 cycles of mFOLFOX6 or FOLFIRI chemotherapy.